Boardroom Alpha
Boardroom Alpha
DOC · Current Report (Form 8-K) · Filed May 4, 2026

Healthpeak Properties Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 4, 2026
Period
Apr 30, 2026
Ticker
DOC
Accession
0000765880-26-000002
Boardroom Alpha · Filing insights

Stockholders elected all directors, approved executive compensation, and ratified Deloitte as auditor; board size reduced to nine.

About Healthpeak Properties Inc
Market cap
$13.4B
1Y TSR
+17.7%
3Y TSR
+4.2%
Board grade
C
Sector
Real Estate
CEO
Scott M Brinker
Last annual meeting: Apr 30, 2026 · View full Healthpeak Properties Inc profile →
peak-20260430

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
April 30, 2026
Date of Report (Date of earliest event reported)

Healthpeak Properties, Inc.
(Exact name of registrant as specified in its charter)
Maryland 001-08895 33-0091377
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
 
4600 South Syracuse Street, Suite 500
Denver, CO 80237
(Address of principal executive offices) (Zip Code)
 
(720) 428-5050
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par valueDOCNew York Stock Exchange
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 5.07 Submission of Matters to a Vote of Security Holders.

Healthpeak Properties, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) on April 30, 2026. At the Annual Meeting, there were present, in person or by proxy, 632,249,628 shares of the Company’s common stock, which represented approximately 91% of the shares entitled to vote and constituted a quorum. Set forth below are the voting results for the three proposals considered and voted upon at the Annual Meeting. Each proposal and the voting standard for that proposal were described in the Proxy Statement.

Proposal 1. All of the nominees listed below were elected to the Board of Directors of the Company (the "Board"), each having received the affirmative vote of a majority of the votes cast. Immediately following the Annual Meeting, the size of the Board was reduced to nine members.
ForAgainstAbstainBroker Non-Votes% of Votes Cast Supporting
Scott M. Brinker584,377,4641,939,714893,81545,038,63599.7%
Katherine M. Sandstrom565,234,32221,091,489885,18245,038,63596.4%
John T. Thomas584,858,1851,429,228923,58045,038,63599.8%
Brian G. Cartwright576,543,2329,745,992921,76945,038,63598.3%
James B. Connor572,180,96114,104,793925,23945,038,63597.6%
R. Kent Griffin, Jr.583,541,1332,748,162921,69845,038,63599.5%
Sara G. Lewis578,941,5836,889,4461,379,96445,038,63598.8%
Ava E. Lias-Booker580,428,6425,390,5391,391,81245,038,63599.1%
Richard A. Weiss585,257,9281,034,993918,07245,038,63599.8%

Proposal 2. The advisory vote to approve 2025 executive compensation was approved.

ForAgainstAbstainBroker Non-Votes% of Votes Cast Supporting
522,635,66463,010,8651,564,464
45,038,635
89.2%

Proposal 3. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved.

ForAgainstAbstainBroker Non-Votes% of Votes Cast Supporting
613,823,29317,504,933921,402N/A97.2%





SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 4, 2026 
Healthpeak Properties, Inc.
 
  
  
 By:/s/ Tracy A. Porter
  Tracy A. Porter
  Executive Vice President and General Counsel


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Healthpeak Properties Inc (DOC)

Reference

Frequently asked questions

When did Healthpeak Properties Inc file this 8-K?
Healthpeak Properties Inc (DOC) filed this Current Report (Form 8-K) with the SEC on May 4, 2026. The accession number assigned by EDGAR is 0000765880-26-000002.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected all directors, approved executive compensation, and ratified Deloitte as auditor; board size reduced to nine. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Healthpeak Properties Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Healthpeak Properties Inc has filed under CIK 765880, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer